Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1131588-12-9

1131588-12-9

Post Buying Request

1131588-12-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1131588-12-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1131588-12-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,3,1,5,8 and 8 respectively; the second part has 2 digits, 1 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1131588-12:
(9*1)+(8*1)+(7*3)+(6*1)+(5*5)+(4*8)+(3*8)+(2*1)+(1*2)=129
129 % 10 = 9
So 1131588-12-9 is a valid CAS Registry Number.

1131588-12-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-Iodo-4-propoxybenzoic acid

1.2 Other means of identification

Product number -
Other names 3-iodanyl-4-propoxy-benzoic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1131588-12-9 SDS

1131588-12-9Upstream product

1131588-12-9Downstream Products

1131588-12-9Relevant articles and documents

S1P RECEPTORS MODULATORS

-

Page/Page column 108, (2010/04/30)

The invention relates to novel compounds that have S1P receptor modulating activity and, preferably, apoptotic activity and/or anti proliferative activity against cancer cells and other cell types. Further, the invention relates to a pharmaceutical comprising at least one compound of the invention for the treatment of diseases and/or conditions caused by or associated with inappropriate S1P receptor modulating activity or expression, for example, cancer. A further aspect of the invention relates to the use of a pharmaceutical comprising at least one compound of the invention for the manufacture of a medicament for the treatment of diseases and/or conditions caused by or associated with inappropriate S1P receptor modulating activity or expression such as cancer.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1131588-12-9